Skip to main content

Table 2 Characteristics of YA ALL survivors and siblings

From: Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings

 

N

YA ALL survivors

N

Siblings

P-value

Age, median (range)

227

28 (23–41)

70

28 (18–44)

0.560

Gender, female, n (%)

227

115 (51)

70

45 (64)

0.046

Marital status, n (%)

224

 

70

 

0.414

Married or cohabitant

 

137 (61)

 

39 (56)

 

In a relationship

 

20 (9)

 

10 (14)

 

Single

 

67 (30)

 

21 (30)

 

Having (any) children, n (%)

226

69 (31)

70

24 (34)

0.728

Education

226

 

70

 

0.272

Compulsory school (9-yrs)

 

12 (5)

 

2 (3)

 

Upper seconday school (2–3 years)

 

109 (48)

 

27 (39)

 

University < 3 yrs

 

29 (13)

 

9 (13)

 

University > 3 yrs

 

76 (34)

 

32 (46)

 

Occupational status, n (%)

226

 

70

 

0.040

Student

 

36 (16)

 

17 (24)

 

Working

 

15 (70)

 

45 (64)

 

Unemployed

 

16 (7)

 

1 (1)

 

On sick-leave/disability pension

 

6 (3)

 

0

 

On parental leave

 

9 (4)

 

6 (9)

 

Other

 

2 (1)

 

1 (1)

 

Monthly Income (€), n (%)

223

 

68

 

0.334

 < 1000

 

61 (27)

 

18 (27)

 

1000–1 900

 

40 (18)

 

9 (13)

 

2000–2 900

 

92 (41)

 

25 (37)

 

3000–3 900

 

21 (9)

 

12 (18)

 

4000–4 900

 

7 (3)

 

4 (6)

 

 ≥ 5000

 

2 (1)

 

0 (0)

 

Physical training, n (%)

226

 

70

 

 < 0.001

Inactive

 

73 (32)

 

8 (11)

 

Active

 

100 (44)

 

49 (70)

 

Very active

 

53 (24)

 

13 (19)

 

BMI, n (%)

202

 

58

 

0.684

 < 18.5

 

4 (2)

 

0

 

19–24

 

114 (56)

 

36 (62)

 

25–29

 

57 (28)

 

16 (28)

 

30–34

 

18 (9)

 

5 (9)

 

 > 34

 

9 (5)

 

1 (2)

 

Comorbidity, n (%)

     

CVD

226

14 (6)

68

0 (0)

 < 0.05

Respiratory disease

226

19 (8)

69

8 (12)

0.422

Headache/migrane

215

77 (36)

70

28 (40)

0.528

Ulcer disease

225

3 (1)

69

0 (0)

0.335

Diabetes

226

3 (1)

70

0 (0)

0.333

Renal disease

209

8 (4)

70

2 (3)

0.491

Connective tissue disease

210

5 (2)

70

0 (0)

0.193

Cancer

212

6 (3)

69

1 (1)

0.513

Liver disease

215

2 (1)

70

0 (0)

0.418